High Sierra Technologies, Inc.

2023 Q4 Form 10-Q Financial Statement

#000154812323000182 Filed on December 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.33K $2.310K
YoY Change 650.22% -95.06%
Cash & Equivalents $17.33K $2.307K
Short-Term Investments
Other Short-Term Assets $1.500K $1.250K
YoY Change 20.0%
Inventory
Prepaid Expenses $1.495K
Receivables
Other Receivables
Total Short-Term Assets $18.83K $3.561K
YoY Change 428.7% -92.39%
LONG-TERM ASSETS
Property, Plant & Equipment $46.98K $105.7K
YoY Change -55.55% 6.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $46.98K $105.7K
YoY Change -55.55% 6.55%
TOTAL ASSETS
Total Short-Term Assets $18.83K $3.561K
Total Long-Term Assets $46.98K $105.7K
Total Assets $65.80K $109.2K
YoY Change -39.76% -25.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $173.3K $125.1K
YoY Change 38.54% -27.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $13.31K $13.31K
YoY Change 0.0% 0.0%
Long-Term Debt Due $434.7K $375.5K
YoY Change 15.77% 0.0%
Total Short-Term Liabilities $646.3K $513.9K
YoY Change 25.77% -8.27%
LONG-TERM LIABILITIES
Long-Term Debt $176.3K $200.0K
YoY Change -11.86% 100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $176.3K $200.0K
YoY Change -11.85% 100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $646.3K $513.9K
Total Long-Term Liabilities $176.3K $200.0K
Total Liabilities $822.6K $713.9K
YoY Change 15.23% 8.13%
SHAREHOLDERS EQUITY
Retained Earnings -$1.750M -$1.359M
YoY Change 28.78%
Common Stock $992.5K $754.4K
YoY Change 31.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$757.7K -$604.6K
YoY Change
Total Liabilities & Shareholders Equity $65.80K $109.2K
YoY Change -39.76% -25.17%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
87171 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
83239 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
385500 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20494645 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20631035 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20641749 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52036
dei Entity Registrant Name
EntityRegistrantName
HIGH SIERRA TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1344320
dei Entity Address Address Line1
EntityAddressAddressLine1
1495 Ridgeview Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230A
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89519
dei City Area Code
CityAreaCode
(775)
dei Local Phone Number
LocalPhoneNumber
410-4100
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20641749 shares
CY2023Q3 us-gaap Cash
Cash
17332 usd
CY2022Q4 us-gaap Cash
Cash
12258 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1495 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1457 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
10401 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
18827 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
24116 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46975 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77386 usd
CY2023Q3 us-gaap Assets
Assets
65802 usd
CY2022Q4 us-gaap Assets
Assets
101502 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
395500 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
385500 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
39219 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
33239 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
163136 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
120777 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
646318 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
561785 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
176294 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
50000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
176294 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
50000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
822612 usd
CY2022Q4 us-gaap Liabilities
Liabilities
611785 usd
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20641749 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20641749 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20616749 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20616749 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
992490 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
954383 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1750190 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1464666 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
890 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-756810 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-510283 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65802 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
101502 usd
CY2023Q3 us-gaap Depreciation
Depreciation
10137 usd
CY2022Q3 us-gaap Depreciation
Depreciation
10428 usd
us-gaap Depreciation
Depreciation
30411 usd
us-gaap Depreciation
Depreciation
28103 usd
CY2023Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
16574 usd
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
5000 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
35873 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
19000 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
41476 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
11715 usd
us-gaap Professional Fees
ProfessionalFees
120914 usd
us-gaap Professional Fees
ProfessionalFees
57405 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5021 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7731 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38236 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62872 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
73208 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
34874 usd
us-gaap Operating Expenses
OperatingExpenses
225434 usd
us-gaap Operating Expenses
OperatingExpenses
167380 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-73208 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-34874 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-225434 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-167380 usd
CY2023Q3 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
3155 usd
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
10381 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
17638 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
17132 usd
us-gaap Interest Expense
InterestExpense
48432 usd
us-gaap Interest Expense
InterestExpense
49808 usd
CY2023Q3 hsti Interestexpense Related Party
InterestexpenseRelatedParty
485 usd
CY2022Q3 hsti Interestexpense Related Party
InterestexpenseRelatedParty
402 usd
hsti Interestexpense Related Party
InterestexpenseRelatedParty
1277 usd
hsti Interestexpense Related Party
InterestexpenseRelatedParty
1194 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
21278 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
17534 usd
us-gaap Other Expenses
OtherExpenses
60090 usd
us-gaap Other Expenses
OtherExpenses
51002 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94486 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52408 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-285524 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-218382 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-94486 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-52408 usd
us-gaap Profit Loss
ProfitLoss
-285524 usd
us-gaap Profit Loss
ProfitLoss
-218382 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-110 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-94486 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-52408 usd
us-gaap Net Income Loss
NetIncomeLoss
-285414 usd
us-gaap Net Income Loss
NetIncomeLoss
-218382 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20641749 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20494645 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20631035 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20489639 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-436265 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-114054 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-500319 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-51920 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-552239 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-52408 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-604647 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-510283 usd
CY2023Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
1000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3294 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-95144 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-601133 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-96004 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-672137 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
9813 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-94486 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-756810 usd
us-gaap Profit Loss
ProfitLoss
-285524 usd
us-gaap Profit Loss
ProfitLoss
-218382 usd
us-gaap Depreciation
Depreciation
30411 usd
us-gaap Depreciation
Depreciation
28103 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
10381 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
46428 usd
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
38 usd
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
-1457 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-10401 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
42359 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28018 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1194 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
1195 usd
hsti Increase In Advanced Royalties
IncreaseInAdvancedRoyalties
25000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-119388 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-159609 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43435 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43435 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
890 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
15000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
103572 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
124462 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5074 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-53044 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12258 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55351 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17332 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2307 usd
us-gaap Interest Paid Net
InterestPaidNet
16328 usd
us-gaap Interest Paid Net
InterestPaidNet
14578 usd
hsti Debt Discount
DebtDiscount
6878 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Nature of Operations</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Gulf &amp; Orient Steamship Company, LTD. (“Gulf”) was incorporated in the State of Colorado on May 9, 1996. Gulf originally intended to engage in the business of marine transportation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2018, Gulf entered into a Share Exchange Agreement with High Sierra Technologies, Inc., a Nevada corporation (“High Sierra”), and all of its shareholders. The shareholders of High Sierra were issued shares of the Gulf’s common stock on a one for one share basis in exchange for their shares of High Sierra’s common stock.  High Sierra became a wholly owned subsidiary of Gulf in the business combination. The Share Exchange was treated as a reverse merger and recapitalization, and as a result, <span>the consolidated financial statements are presented under successor entity reporting, with an inception date of August 6, 2018. Subsequently Gulf’s name was changed to High Sierra Technologies, Inc. (together with its subsidiaries, the “Company”).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">High Sierra was incorporated in the State of Nevada on August 6, 2018. It was formed with the intention that it would become the assignee, owner and licensor of certain Intellectual Property (the “Intellectual Property”) that was, prior to assignment, the property of Vincent C. Lombardi, Ph.D., who is an officer, director and co-founder of High Sierra.  High Sierra was further formed with the goal that it would continue to develop and expand its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a start-up that develops patents and other products used in the processing of cannabis, including industrial hemp, and will license these technologies to companies in the industry.  The Company will likely incur research and development expenses in the future and intends to develop a policy regarding the same.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 17, 2022, High Sierra executed a Joint Venture Agreement (the “Joint Venture Agreement”) with Hempacco Co., Inc. (“Hempacco”) for the production, marketing, and sales of hemp smokables that will use the Company’s patented and patent-pending technologies, as well as certain patented and patent-pending technologies held by Hempacco. Pursuant to this Joint Venture Agreement, High Sierra and Hempacco formed a new Nevada corporation known as Organipure, Inc. (“Organipure”). High Sierra and Hempacco each own one-half of the equity interests in Organipure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the execution of the Joint Venture Agreement, Hempacco also entered a Hemp Smokables Manufacturing Agreement with Organipure (the “Manufacturing Agreement”), pursuant to which Hempacco will act as Organipure’s exclusive worldwide manufacturer and supplier of hemp smokables, subject to the terms and conditions of the Manufacturing Agreement.  The hemp smokables will be manufactured according to product specifications and packaging described in the Manufacturing Agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Also, in connection with the execution of the Joint Venture Agreement, High Sierra entered into a Patent License Agreement with Organipure (the “HSTI Patent License Agreement”), which granted Organipure a non-exclusive license of High Sierra’s patented and patent-pending technologies to be used in connection with the hemp smokable products to be produced, marketed, and sold by Organipure.  The annual license fee will be 5% of Organipure’s gross receipts from the use of the High Sierra patents by Organipure.  The term of the license expires December 31, 2033, unless terminated earlier for reasons specified in the HSTI Patent License Agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Similarly, Hempacco entered into a Patent License Agreement with Organipure (the “Hempacco Patent License Agreement”) which granted to Organipure a non-exclusive license of Hempacco’s patented and patent pending technologies to be used in connection with the hemp smokable products.  The annual license fee will be 5% of Organipure’s gross receipts from the use of the Hempacco patents by Organipure.  The term of the license expires December 31, 2033, unless terminated earlier for reasons specified in the Hempacco Patent License Agreement.   </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Hempacco is an industry leader in the hemp smokables market space.  Hempacco’s state-of-the-art production facility provides it with superior production capabilities that allow it to be able to currently produce over 30 million hemp cigarettes per month with the ability to quickly expand its production capabilities with very short notice.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This is the first use of the patented technology developed by High Sierra. Recently, Organipure began production of hemp smokables using the patented technology developed by High Sierra. Organipure expects to begin generating revenue in the fourth quarter of 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is currently looking for other opportunities in the hemp/CBD market and has signed certain Letters of Intent it is seeking to concurrently fund and close.</p>
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.05 pure
us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.05 pure
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
30000000 usd
CY2023Q3 hsti Interest Rate Percentage
InterestRatePercentage
0.50 pure
CY2023Q3 hsti Board Of Directors Percentage
BoardOfDirectorsPercentage
0.50 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Concentration of Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company places its cash and temporary cash investments with established financial institutions.  At times, such cash and investments may be in excess of the FDIC insurance limit.</p>
us-gaap Interest Expense Debt
InterestExpenseDebt
1277 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1194 usd
hsti Note Payable Accrued Interest Related Party
NotePayableAccruedInterestRelatedParty
10157 usd
us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ materially from those estimates.</p>
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.50 pure
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
109999 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
76666 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
33333 shares
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
220184 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
220184 usd
CY2023Q3 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
173209 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
142798 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46975 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
77386 usd
hsti Note Payable Accrued Interest Related Party
NotePayableAccruedInterestRelatedParty
8561 usd
CY2023Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
395500 usd
CY2023Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
128342 usd
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
0 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
611013 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
468739 usd
CY2023Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
395500 usd
CY2022Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
385500 usd
CY2023Q3 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
39219 usd
CY2022Q4 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
33239 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
176294 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
50000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
50000 usd
CY2023Q3 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.03 pure
CY2023Q3 hsti Offering Price Per Share
OfferingPricePerShare
1.5
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.50 pure
us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
1
us-gaap Common Stock Convertible Conversion Price Decrease
CommonStockConvertibleConversionPriceDecrease
1
us-gaap Interest Expense
InterestExpense
48432 usd
us-gaap Interest Expense
InterestExpense
49808 usd
hsti Note Payable Accrued Interest Total
NotePayableAccruedInterestTotal
136227 usd
hsti Note Payable Accrued Interest Total
NotePayableAccruedInterestTotal
100305 usd
hsti Payment Of Accrued Interest Note Payable
PaymentOfAccruedInterestNotePayable
16328 usd
hsti Payment Of Accrued Interest Note Payable
PaymentOfAccruedInterestNotePayable
14578 usd
hsti Warrants Exercised
WarrantsExercised
16667 shares
CY2023Q2 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
25000 shares
CY2023Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
25000 usd
CY2023Q1 hsti Accrued Interest
AccruedInterest
5655 usd
hsti Cash Commission Percentage
CashCommissionPercentage
0.09 pure
CY2023Q3 srt Financing Receivable Allowance For Credit Loss To Outstanding Percent
FinancingReceivableAllowanceForCreditLossToOutstandingPercent
0.01 pure
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1
hsti Gross Proceeds
GrossProceeds
150000 usd
hsti Warrants
Warrants
10000 shares
hsti Warrants Exercised Amount
WarrantsExercisedAmount
100 usd
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16667 shares
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000 usd
CY2022 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
3294 usd
CY2023Q1 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
3294 usd
CY2023Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
10500 shares
CY2023Q3 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
9813 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
66667 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
20500 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
87167 shares
hsti Fixed Variable
FixedVariable
65900 usd
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
87167 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
0.76
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y1M2D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0442 pure
hsti Expected Lifeyear
ExpectedLifeyear
P5Y
CY2023Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1
CY2021Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
1475 sqm
CY2021Q4 us-gaap Payments For Rent
PaymentsForRent
1253.75 usd
CY2021Q4 hsti Common Area Maintenance Charges
CommonAreaMaintenanceCharges
203.5 usd
CY2023Q3 us-gaap Advance Rent
AdvanceRent
1291.36 usd
hsti Common Area Maintenance Charges Remained Same
CommonAreaMaintenanceChargesRemainedSame
-203.5 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
13416 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
11658 usd
CY2023Q3 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1609 usd
CY2022Q3 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1500 usd
CY2023Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
CY2022Q4 us-gaap Minority Interest
MinorityInterest
usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
usd
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20489639 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
usd
hsti Increase In Advanced Royalties
IncreaseInAdvancedRoyalties
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
hsti Debt Discount
DebtDiscount
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001365388

Files In Submission

Name View Source Status
0001548123-23-000182-index-headers.html Edgar Link pending
0001548123-23-000182-index.html Edgar Link pending
0001548123-23-000182.txt Edgar Link pending
0001548123-23-000182-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hsti-20230930.htm Edgar Link pending
hsti-20230930.xsd Edgar Link pending
hsti-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hsti-20230930_def.xml Edgar Link unprocessable
hsti-20230930_lab.xml Edgar Link unprocessable
hsti-20230930_pre.xml Edgar Link unprocessable
hsti-20230930_htm.xml Edgar Link completed